Therapeutic effect on disodium pamidronate administration to diffuse sclerosing mandible osteomyelitis
Not Applicable
Completed
- Conditions
- diffuse sclerosing osteomyelitis
- Registration Number
- JPRN-UMIN000033725
- Lead Sponsor
- Department of Oral and Maxillofacial Surgery, Osaka Medical and Pharmaceutical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not obtain consent to this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dissolve pamidronate disodium in 500ml of raw diet for patients with diffuse osteomyelitis and take IV infusion over 4 hours. The number of doses is only once, but when symptoms such as pain are observed, re-administration is performed at intervals of 3 to 6 months.Comparison of changes in jaw bone due to clinical symptoms and image findings before and after administration of disodium pamidronate, and evaluate the improvement effect of diamid pamidronate on DSO
- Secondary Outcome Measures
Name Time Method